Symrise announced a strategic equity investment in Cellibre, a U.S.-based biotechnology company specialising in sustainable biomanufacturing. This partnership positions Symrise at the forefront of fermentation-derived ingredients that are better for both people and planet. It will initially focus on innovation across taste solutions and cosmetic actives, reinforcing its long-term competitiveness and sustainability leadership.

By partnering with Cellibre, Symrise gains preferred access to proprietary, fermentation-based technology, enabling scalable production of high-value ingredients across food, beverage, cosmetics, and nutraceutical sectors. With this investment, Symrise will leverage Cellibre’s world-class biotechnology platform to enable a more resilient supply chain, mitigating seasonal and cultivation variability.

Cellibre brings a significant track record in designing and engineering microorganisms for the production of cultured natural products and chemicals that are utilised in pharmaceuticals, functional health, beauty ingredients, industrial applications, and more.

This collaboration supports Symrise’s ambition to integrate biotechnology across its operations, ensuring long-term resilience, portfolio diversification, and competitive advantage. It also aligns with the company’s sustainability commitments and consumer-driven innovation strategy.

As part of its long term strategy to expand its capabilities in bio-engineering technologies, Givaudan announced that it has closed the acquisition of Alderys.

Founded in 2009, Alderys is an innovative French biotechnology company headquartered in Orsay, France, employing 30 employees. Alderys develops innovative approaches to the biological engineering of valuable compounds from renewable feedstock. The projects developed by Alderys are aimed at the chemical and cosmetic industry sectors as well as nutrition. They are recognised for offering innovative technological industrial solutions with high sustainability standards.

While terms of the deal have not been disclosed, Alderys’ business would have represented EUR 3 million of incremental revenues to Givaudan’s results in 2019 on a pro-forma basis. Givaudan funded the transaction from existing resources.

About Givaudan
Givaudan is the global leader in the creation of flavours and fragrances, with its heritage stretching back over 250 years, the Company has a long history of innovating scents and tastes. From a favourite drink to your daily meal, from prestige perfumes to cosmetics and laundry care, its creations inspire emotions and delight millions of consumers the world over. The company is committed to driving purpose-led, long-term growth while leading the way to improve happiness and health for people and nature.  In the fiscal year 2019, the Company employed over 14,900 people worldwide and achieved sales of CHF 6.2 billion and a free cash flow of 12.7% of sales. Let’s imagine together on www.givaudan.com.

About Alderys
Alderys develops innovative approaches to the micro-organic biological engineering of valuable compounds from renewable plant resources. Committed to imaginative, robust scientific practice, they improve yeast cells to transform them into veritable micro production units. Alderys offers innovative technological industrial solutions for the fabrication of products that are indispensable for the growing world and which respect the environment. The projects developed by Alderys are aimed at the chemical, cosmetics and nutrition sectors. Thanks to their technological quality and innovation, Alderys has signed a number of partnership agreements with industry leaders in various fields. Alderys was founded in 2009 by Dominique Thomas in Orsay, France. It employs 30 people. www.alderys.fr/en/